» Articles » PMID: 35446570

Three Mutations Convert the Selectivity of a Protein Sensor from Nicotinic Agonists to S-Methadone for Use in Cells, Organelles, and Biofluids

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2022 Apr 21
PMID 35446570
Authors
Affiliations
Soon will be listed here.
Abstract

We report a reagentless, intensity-based S-methadone fluorescent sensor, iS-methadoneSnFR, consisting of a circularly permuted GFP inserted within the sequence of a mutated bacterial periplasmic binding protein (PBP). We evolved a previously reported nicotine-binding PBP to become a selective S-methadone-binding sensor, via three mutations in the PBP's second shell and hinge regions. iS-methadoneSnFR displays the necessary sensitivity, kinetics, and selectivity─notably enantioselectivity against R-methadone─for biological applications. Robust iS-methadoneSnFR responses in human sweat and saliva and mouse serum enable diagnostic uses. Expression and imaging in mammalian cells demonstrate that S-methadone enters at least two organelles and undergoes acid trapping in the Golgi apparatus, where opioid receptors can signal. This work shows a straightforward strategy in adapting existing PBPs to serve real-time applications ranging from subcellular to personal pharmacokinetics.

Citing Articles

Advances in ligand-specific biosensing for structurally similar molecules.

Xi C, Diao J, Moon T Cell Syst. 2023; 14(12):1024-1043.

PMID: 38128482 PMC: 10751988. DOI: 10.1016/j.cels.2023.10.009.


Antidepressants enter cells, organelles, and membranes.

Blumenfeld Z, Bera K, Castren E, Lester H Neuropsychopharmacology. 2023; 49(1):246-261.

PMID: 37783840 PMC: 10700606. DOI: 10.1038/s41386-023-01725-x.


Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.

Nichols A, Blumenfeld Z, Luebbert L, Knox H, Muthusamy A, Marvin J J Neurosci. 2023; 43(13):2222-2241.

PMID: 36868853 PMC: 10072302. DOI: 10.1523/JNEUROSCI.1519-22.2022.


Fluorescence Screens for Identifying Central Nervous System-Acting Drug-Biosensor Pairs for Subcellular and Supracellular Pharmacokinetics.

Beatty Z, Muthusamy A, Unger E, Dougherty D, Tian L, Looger L Bio Protoc. 2022; 12(22).

PMID: 36532688 PMC: 9724018. DOI: 10.21769/BioProtoc.4551.


Genetically encoded tools for in vivo G-protein-coupled receptor agonist detection at cellular resolution.

Kroning K, Wang W Clin Transl Med. 2022; 12(12):e1124.

PMID: 36446954 PMC: 9708909. DOI: 10.1002/ctm2.1124.

References
1.
Rezaei B, Tajaddodi A, Ensafi A . An innovative highly sensitive electrochemical sensor based on modified electrode with carbon quantum dots and multiwall carbon nanotubes for determination of methadone hydrochloride in real samples. Anal Methods. 2020; 12(43):5210-5218. DOI: 10.1039/d0ay01374a. View

2.
Li Y, Kantelip J, Gerritsen-van Schieveen P, Davani S . Interindividual variability of methadone response: impact of genetic polymorphism. Mol Diagn Ther. 2008; 12(2):109-24. DOI: 10.1007/BF03256276. View

3.
Marvin J, Borghuis B, Tian L, Cichon J, Harnett M, Akerboom J . An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat Methods. 2013; 10(2):162-70. PMC: 4469972. DOI: 10.1038/nmeth.2333. View

4.
Nilsson M, Gronbladh L, Widerlov E, ANGGARD E . Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures. Eur J Clin Pharmacol. 1983; 25(4):497-501. DOI: 10.1007/BF00542117. View

5.
DOLE V, NYSWANDER M . A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA. 1965; 193:646-50. DOI: 10.1001/jama.1965.03090080008002. View